Scholars@Duke
Search form
Search
Advanced Search
Support
Index
Subscribe to Announcements
Menu
Search
Home
People
Schools / Institutes
Research
About
Home
People
Schools / Institutes
Research
Jto Clinical and Research Reports
Publication Venue For
A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial.
. 3:100337.
2022
Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC.
. 2:100208.
2021
